PUBLISHER: The Business Research Company | PRODUCT CODE: 2161049
PUBLISHER: The Business Research Company | PRODUCT CODE: 2161049
Medical device contract micro-molding refers to the specialized outsourced manufacturing of highly miniaturized and precision medical components using injection molding technologies and micro-scale tooling. The process involves molding medical-grade materials into complex geometries with tight dimensional tolerances and high repeatability. These capabilities enable the production of critical components for minimally invasive surgical instruments while satisfying stringent quality, performance, and regulatory requirements.
The primary process types of medical device contract micro-molding include micro injection molding, insert micro-molding, overmolding, micro two-shot or multi-shot molding, and other micro-molding processes. Micro injection molding refers to a precision manufacturing process used to produce very small medical components with complex geometries and tight dimensional tolerances. These processes utilize thermoplastics, liquid silicone rubber, high-performance polymers, and other materials. The various applications include drug delivery devices, implantable medical devices, catheters and cannulas, diagnostic devices, surgical instruments, microfluidic devices, and wearable medical devices, and they are utilized by end users including medical device original equipment manufacturers, pharmaceutical and biotechnology companies, contract development and manufacturing organizations, and research institutes and laboratories.
Tariffs are influencing the medical device contract micro-molding market by increasing the costs of imported medical-grade polymers, precision tooling, molding equipment, and specialized production components required for micro-scale manufacturing. Higher input costs can raise production expenses and create potential delays in component development and manufacturing, particularly in regions dependent on imported materials and equipment such as Asia-Pacific, Europe, and Latin America. Hardware-intensive segments such as high-precision micro-molding, implantable medical device components, and minimally invasive surgical components are particularly affected due to their reliance on global supply chains. However, tariffs can also encourage local sourcing, regional supplier diversification, domestic tooling capabilities, and investment in localized medical component manufacturing, strengthening long-term market resilience.
The medical device contract micro-molding market research report is one of a series of new reports from The Business Research Company that provides medical device contract micro-molding market statistics, including medical device contract micro-molding industry global market size, regional shares, competitors with a medical device contract micro-molding market share, detailed medical device contract micro-molding market segments, market trends and opportunities, and any further data you may need to thrive in the medical device contract micro-molding industry. This medical device contract micro-molding market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The medical device contract micro-molding market size has grown strongly in recent years. It will grow from $1.94 billion in 2025 to $2.07 billion in 2026 at a compound annual growth rate (CAGR) of 6.7%. The growth in the historic period can be attributed to increasing demand for minimally invasive surgical devices, rising need for miniaturized medical components, growing adoption of precision injection molding technologies, increasing complexity of medical device manufacturing, and growing demand for high-repeatability component production.
The medical device contract micro-molding market size is expected to see strong growth in the next few years. It will grow to $2.71 billion in 2030 at a compound annual growth rate (CAGR) of 7.0%. Growth throughout the forecast period is anticipated to be driven by increasing demand for next-generation minimally invasive devices, wider adoption of complex micro-scale component geometries, rising use of automated micro-molding processes, increasing application of advanced medical-grade polymers, and growing outsourcing of precision medical component manufacturing. Major trends during the forecast period include increasing adoption of high-precision medical micro-molding, rising demand for miniaturized medical components, greater use of advanced medical-grade molding materials, growing need for tight dimensional tolerances in molded components, and increasing outsourcing of specialized micro-molding production.
The increasing miniaturization of medical devices is expected to propel the growth of the medical device contract micro-molding market going forward. Miniaturization of medical devices refers to the development of smaller, lighter, and more compact medical devices and components while maintaining or enhancing their functionality, performance, and reliability. The miniaturization of medical devices is increasing due to the growing demand for minimally invasive procedures, wearable medical technologies, implantable devices, and compact diagnostic systems, which require smaller and increasingly complex components. Medical device contract micro-molding enables manufacturers to produce highly precise miniature components with complex geometries, tight dimensional tolerances, and consistent repeatability, supporting the development of increasingly compact medical devices. For instance, in 2024, according to The IP&E Specialist, a US-based industry publication, a survey of medical-device design professionals found that 85% of respondents considered miniaturization a critical design consideration, emphasizing the growing importance of smaller and more compact medical devices. Therefore, the increasing miniaturization of medical devices is driving the growth of the medical device contract micro-molding market.
Major companies operating in the medical device contract micro-molding market are concentrating on expanding outsourced precision micro-molding capabilities to address the increasing demand for miniaturized medical devices, including micro-molded components for minimally invasive surgical instruments, wearable sensors, and drug delivery systems. Precision micro-molding is a specialized contract manufacturing process that produces extremely small, high-tolerance medical components using advanced tooling, cleanroom manufacturing, and micron-level injection molding technologies, allowing OEMs to accelerate product development while reducing the need for substantial capital investment. For instance, in May 2026, Nissha Medical Technologies, a Japan-based medical device CDMO, expanded its Isometric Micro Molding operations by breaking ground on a new 50,000-square-foot manufacturing facility in Wisconsin, U.S. The new facility is expected to more than double the company's capacity in micro-tool making, automation, development, and injection molding while supporting the production of precision-molded components for minimally invasive surgical devices, surgical robotics, diagnostic equipment, and wearable medical sensors.
In June 2026, Cordica Medical Inc., a U.S.-based contract development and manufacturing organization (CDMO), acquired the micro-molding capabilities of RapidWerks Inc. for an undisclosed amount. The acquisition strengthened Cordica Medical's vertically integrated manufacturing platform by adding fully automated precision micro-molding capabilities for manufacturing sub-gram, micron-tolerance medical components using advanced materials such as PEEK and bioresorbable polymers. RapidWerks Inc. is a U.S.-based precision micro-molding company specializing in micro injection molding, insert molding, tool fabrication, and contract manufacturing for miniaturized medical devices, serving cardiovascular, orthopedic, neurology, and pharmaceutical applications.
Major companies operating in the medical device contract micro-molding market are Accumold LLC, MTD Micro Molding Inc, Nissha Medical Technologies Inc, Saint-Gobain SA, Freudenberg Medical LLC, Tessy Plastics Corporation, Viant Medical Inc, Ensinger GmbH, Phillips-Medisize Corporation, ARTEREX, SMC Ltd, Tegra Medical LLC, SIMTEC Silicone Parts LLC, Makuta Micro Molding Inc, Inventex Medical, Veejay Plastic Injection Molding Company, Microtech Engineers, PDC, Micro Systems UK Ltd, DuPont de Nemours Inc, Merit Medical Systems Inc, West Pharmaceutical Services Inc, Putnam Plastics Corporation
North America was the dominating region in the medical device contract micro-molding market in 2025. Asia-Pacific is expected to be the rapidly growing region in the forecast period. The regions covered in the medical device contract micro-molding market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the medical device contract micro-molding market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The medical device contract micro-molding market includes revenues earned by entities through micro compression molding, micro transfer molding, micro reaction injection molding (Micro-RIM) and micro insert and assembly molding. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Medical Device Contract Micro-Molding Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses medical device contract micro-molding market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Where is the largest and fastest growing market for medical device contract micro-molding? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The medical device contract micro-molding market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
Added Benefits available on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope are limited to 20% of content and consultant support time is limited to 8 hours.